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Résumé en
anglais
Inhaled fluticasone propionate (FP) is often prescribed as a first-line therapy for the
effective management of pulmonary diseases such as asthma. As nanocarriers offer
many advantages over other drug delivery systems, this study investigated the
suitability of lipid nanocapsules (LNCs) as a carrier for fluticasone propionate,
examining the drug-related factors that should be considered in the formulation
design and the behaviour of LNCs with different compositions and properties
suspended within aerosol droplets under the relatively hostile conditions of
nebulization. By adjusting the formulation conditions, particularly the nanocarrier
composition, FP was efficiently encapsulated within the LNCs with a yield of up to
97%, and a concentration comparable to commercially available preparations was
achieved. Moreover, testing the solubility of the drug in oil and water and
determining the oil/water partition coefficient proved to be useful when assessing
the encapsulation of the FP in the LNC formulation. Nebulization did not cause the
FP to leak from the formulation, and no phase separation was observed after
nebulization. LNCs with a diameter of 100nm containing a smaller amount of
surfactant and a larger amount of oil provided a better FP-loading capacity and
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